These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1712134)

  • 21. Changes in the contact system during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1995 Feb; 59(3):366-70. PubMed ID: 7532878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation.
    Neuhaus P; Bechstein WO; Lefèbre B; Blumhardt G; Slama K
    Lancet; 1989 Oct; 2(8668):924-5. PubMed ID: 2477657
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
    Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
    Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of aprotinin in orthotopic liver transplantation.
    Suárez M; Sangro B; Herrero JI; Picardi A; Páramo JA; Quiroga J; Pardo F; Cienfuegos J; Carrera J; Hidalgo F
    Semin Thromb Hemost; 1993; 19(3):292-6. PubMed ID: 7689754
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Downing A; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1994 Dec; 58(12):1356-60. PubMed ID: 7528949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reduction of blood loss in orthotopic liver transplantation with the use of aprotinin].
    Légaré G; Roy A; Dagenais M; Lapointe R; Marleau D; Thuot C
    Ann Chir; 1996; 50(8):601-5. PubMed ID: 9035431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aprotinin in the control of surgical hemorrhage].
    Rocha E; Antonio Páramo J; Hermida J
    Med Clin (Barc); 1996 Mar; 106(8):307-16. PubMed ID: 8667690
    [No Abstract]   [Full Text] [Related]  

  • 29. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty.
    Langdown AJ; Field J; Grote J; Himayat H
    J Arthroplasty; 2000 Dec; 15(8):1009-12. PubMed ID: 11112196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective randomized placebo-controlled trial of aprotinin for elective aortic reconstruction.
    Ranaboldo CJ; Thompson JF; Davies JN; Shutt AM; Francis JN; Roath OS; Webster JH; Chant AD
    Br J Surg; 1997 Aug; 84(8):1110-3. PubMed ID: 9278654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical haemostasis in acute hepatocyte injury and experimental liver trauma.
    Cihan A; Yilmaz E; Yenidünya S; Uçan BH
    ANZ J Surg; 2005 Apr; 75(4):239-43. PubMed ID: 15839974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aprotinin: safe and effective in all patients undergoing orthotopic liver transplantation?
    Porte RJ; Slooff MJ
    Liver Transpl; 2001 Sep; 7(9):808-10. PubMed ID: 11552216
    [No Abstract]   [Full Text] [Related]  

  • 33. Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization.
    Minami K; Notohamiprodjo G; Buschler H; Prohaska W; Reichelt W; Körfer R
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):934-6. PubMed ID: 7694000
    [No Abstract]   [Full Text] [Related]  

  • 34. Temporary portocaval anastomosis with preservation of caval flow during orthotopic liver transplantation.
    Belghiti J; Noun R; Sauvanet A
    Am J Surg; 1995 Feb; 169(2):277-9. PubMed ID: 7840394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Massive bleeding due to hyperfibrinolysis during living-related liver transplantation for terminal liver cirrhosis; report of two cases].
    Kaku R; Matsumi M; Ichiyama M; Kajihara H; Fujii H; Ohashi I; Mizobuchi S; Morita K
    Masui; 2003 Nov; 52(11):1195-9. PubMed ID: 14661565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aprotinin prevents bleeding and has effects on platelets and fibrinolysis.
    Royston D
    J Cardiothorac Vasc Anesth; 1991 Dec; 5(6 Suppl 1):18-23. PubMed ID: 1722426
    [No Abstract]   [Full Text] [Related]  

  • 37. Aprotinin (trasylol) up-to-date.
    Drug Ther Bull; 1969 Jun; 7(12):46-8. PubMed ID: 5306824
    [No Abstract]   [Full Text] [Related]  

  • 38. Antifibrinolytics in liver transplantation.
    Groenland TH; Porte RJ
    Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208
    [No Abstract]   [Full Text] [Related]  

  • 39. Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss.
    Flight SM; Johnson LA; Du QS; Warner RL; Trabi M; Gaffney PJ; Lavin MF; de Jersey J; Masci PP
    Br J Haematol; 2009 Apr; 145(2):207-11. PubMed ID: 19236611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of hanging maneuvers in orthotopic liver transplantation with inferior vena cava preservation and in liver surgery.
    Ettorre GM; Vennarecci G; Boschetto A; Douard R; Santoro E
    J Hepatobiliary Pancreat Surg; 2004; 11(3):155-8. PubMed ID: 15235886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.